NRGEX | NRGSX | NRGEX / NRGSX | |
Total Expense Ratio | 0.03 | 0.74 | 4% |
Annual Report Gross Expense Ratio | 0.69 | 0.74 | 93% |
Fund Existence | 4 years | 13 years | - |
Gain YTD | -3.342 | -3.902 | 86% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.71B | 8.71B | 100% |
Annual Yield % from dividends | 0.54 | 0.06 | 828% |
Returns for 1 year | -9.46 | -10.12 | 93% |
Returns for 3 years | 8.17 | 5.90 | 138% |
Returns for 5 years | N/A | -2.32 | - |
Returns for 10 years | N/A | 10.24 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNIX | 75.85 | 0.47 | +0.62% |
Janus Henderson Global Life Sciences I | |||
TICSX | 7.39 | 0.04 | +0.54% |
Touchstone Small Company Instl | |||
GSVPX | 16.76 | 0.05 | +0.30% |
Goldman Sachs Small/Mid Cap Equity P | |||
RLBBX | 38.66 | 0.03 | +0.08% |
American Funds American Balanced R2 | |||
SGQCX | 42.96 | -0.03 | -0.07% |
DWS International Growth C |